Involvement of Akt, Ras and cell cycle regulators in the potential development of endometrial hyperplasia in women with polycystic ovarian syndrome
- PMID: 19631369
- PMCID: PMC3441142
- DOI: 10.1016/j.ygyno.2009.06.033
Involvement of Akt, Ras and cell cycle regulators in the potential development of endometrial hyperplasia in women with polycystic ovarian syndrome
Abstract
Objective: To examine whether the abundance, localization, and/or activity of cell cycle regulators CDK2, Cyclin E, p27, and survival proteins AKT and Ras in PCOS-associated endometria (with and without hyperplasia) differ from non-PCOS endometria.
Methods: The expression of CDK2, Cyclin E, p27, AKT and Ras was measured by immunohistochemistry and/or Western blot in 9 normal endometria (NE), 12 endometria from PCOS patients without endometrial hyperplasia (PCOSE), 7 endometria from PCOS women with endometrial hyperplasia (HPCOSE), and 9 endometria from patients with endometrial hyperplasia (HE). The activity of CDK2 was assessed by an in vitro kinase assay.
Results: CDK2, Cyclin E and p27 proteins were expressed mainly in the endometrial epithelial cells of the studied groups. No change in the activity of CDK2 was observed in total extracts obtained from the tissue samples. However, the nuclear expression of CDK2 in epithelial cells was slightly elevated in PCOSE and significantly increased in HPCOSE when compared to NE. Higher expression of p27 was detected in the cytoplasm of epithelial cells of PCOSE and HPCOSE when compared to NE. Also, we found an increment in Ser473-AKT phosphorylation and an over-expression of the Ras oncogene in endometria of patients with PCOS.
Conclusion: The PCOS condition is associated with increased Ser473-AKT phosphorylation, elevated expression of Ras, increased cytoplasmic abundance of p27, and increased nuclear abundance of CDK2 in the endometrial epithelial cells. These biological events could potentially provide a chance for endometrial cells from PCOS patients to exit the controlled cell cycle and become hyperplastic at a later stage.
Conflict of interest statement
The authors declare that there are no conflicts of interest.
Figures




Similar articles
-
Androgen and estrogen receptors and co-regulators levels in endometria from patients with polycystic ovarian syndrome with and without endometrial hyperplasia.Gynecol Oncol. 2006 Oct;103(1):307-14. doi: 10.1016/j.ygyno.2006.03.029. Epub 2006 May 3. Gynecol Oncol. 2006. PMID: 16677694
-
Deregulation of tissue homeostasis in endometria from patients with polycystic ovarian syndrome with and without endometrial hyperplasia.Gynecol Oncol. 2007 Feb;104(2):290-5. doi: 10.1016/j.ygyno.2006.09.003. Epub 2006 Oct 9. Gynecol Oncol. 2007. PMID: 17030058
-
Levels of Regulatory Proteins Associated With Cell Proliferation in Endometria From Untreated Patients Having Polycystic Ovarian Syndrome With and Without Endometrial Hyperplasia.Reprod Sci. 2016 Feb;23(2):211-8. doi: 10.1177/1933719115597762. Epub 2015 Aug 2. Reprod Sci. 2016. PMID: 26239387
-
In situ estrogen metabolism in proliferative endometria from untreated women with polycystic ovarian syndrome with and without endometrial hyperplasia.J Steroid Biochem Mol Biol. 2008 May;110(1-2):163-9. doi: 10.1016/j.jsbmb.2008.03.031. Epub 2008 Apr 1. J Steroid Biochem Mol Biol. 2008. PMID: 18467089
-
Lower expression of ER-α36 is associated with the development of endometrial hyperplasia in PCOS patients.Histol Histopathol. 2013 Nov;28(11):1491-8. doi: 10.14670/HH-28.1491. Epub 2013 May 21. Histol Histopathol. 2013. PMID: 23690166
Cited by
-
Integrated bioinformatics and network pharmacology to explore the therapeutic target and molecular mechanisms of Bailing capsule on polycystic ovary syndrome.BMC Complement Med Ther. 2023 Dec 15;23(1):458. doi: 10.1186/s12906-023-04280-6. BMC Complement Med Ther. 2023. PMID: 38102584 Free PMC article.
-
Growth hormone activates PI3K/Akt signaling and inhibits ROS accumulation and apoptosis in granulosa cells of patients with polycystic ovary syndrome.Reprod Biol Endocrinol. 2020 Dec 7;18(1):121. doi: 10.1186/s12958-020-00677-x. Reprod Biol Endocrinol. 2020. PMID: 33287836 Free PMC article. Clinical Trial.
-
Proteome analysis of endometrial tissue from patients with PCOS reveals proteins predicted to impact the disease.Mol Biol Rep. 2020 Nov;47(11):8763-8774. doi: 10.1007/s11033-020-05924-3. Epub 2020 Oct 24. Mol Biol Rep. 2020. PMID: 33098551
-
Changes in the expression of insulin signaling pathway molecules in endometria from polycystic ovary syndrome women with or without hyperinsulinemia.Mol Med. 2010 Mar;16(3-4):129-36. doi: 10.2119/molmed.2009.00118. Epub 2009 Dec 4. Mol Med. 2010. PMID: 20011249 Free PMC article.
-
Genome-wide DNA methylation and gene expression patterns provide insight into polycystic ovary syndrome development.Oncotarget. 2014 Aug 30;5(16):6603-10. doi: 10.18632/oncotarget.2224. Oncotarget. 2014. PMID: 25051372 Free PMC article.
References
-
- Nardo LG, Patchava S, Laing I. Polycystic ovary syndrome: pathophysiology, molecular aspects and clinical implications. Panminerva Med. 2008;50:267–278. - PubMed
-
- Hart R. PCOS and infertility. Panminerva Med. 2008;50:305–314. - PubMed
-
- Balen A. Polycystic ovary syndrome and cancer. Hum Reprod Update. 2001;7:522–525. - PubMed
-
- Schmeler KM, Soliman PT, Sun CC, Slomovitz BM, Gershenson DM, Lu KH. Endometrial cancer in young, normal-weight women. Gynecol Oncol. 2005;99:388–392. - PubMed
-
- Pillay OC, Te Fong LF, Crow JC, Benjamin E, Mould T, Atiomo W, et al. The association between polycystic ovaries and endometrial cancer. Hum Reprod. 2006;21:924–929. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous